Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cytosine Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106478751B details a pyridine-free route for capecitabine intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN1022688C discloses novel 5'-deoxy-5-fluorocytidine derivatives with reduced toxicity. Discover cost-effective manufacturing and supply chain solutions for high-purity API intermediates.
Patent CN112480197B reveals a cost-effective route for cytosine nucleoside using cyanoacetaldehyde urea acetal, offering significant supply chain advantages.
Novel 3-step synthesis of Cytosine Nucleoside from cyanoacetaldehyde urea acetal. High yield, cost-effective route for antiviral API manufacturing.